to 200% increase in heparin releasable and in a 40% to 130% increase in cellular 125 I-LDL. Thus, the increase in 125 I-LDL binding and uptake in verapamil-treated cells was apparently due to an increase in receptor number, rather than in receptor affinity. The effect of verapamil on LDL uptake and degradation was also seen in cells that were pretreated for 24 hours and incubated with 12S I-LDL in the absence of verapamil. The effect of verapamil was not apparent in LDL receptor-negative cells. Cycloheximide blocked the verapamil effect. The Na+ channel blocker, tetrodotoxin x 10~6 M, caused a 30% to 50% increase in the total amount of LDL endocytosed, but no delay in LDL degradation; amiloride 2 x 10~3 M was not effective. If the presently described effect of verapamil also occurs in vivo, this might contribute to the reported beneficial effects of Ca+ + channel blockers in experimental atherosclerosis by promoting transfer of LDL cholesteryl ester from the aortic interstitium to a catabolic compartment.
T he receptor-mediated endocytosis of low density lipoprotein (LDL) has been studied exhaustively, and the various stages of this pathway have been elucidated. 1 Perturbation of the intracellular part of the pathway was achieved by treatment of cultured cells with weak basic amines, which inhibit the action of lysosomal hydrolases and thus lead to accumulation of esterified cholesterol (EC). 23 Even though the need for the recycling of the apo B receptor was suggested several years ago, 4 new experimental evidence has been only recently obtained with the help of the Na ionophore, monensin. 5 In addition, the clustering of apo B receptors in coated pits could be inhibited in K + -depleted cells. 6 Thus, it appears that ions may play a role in the process of LDL endocytosis not only by influencing the binding of the ligand to its receptor, as was shown 7 for Ca+ + .
During the past few years, attenuation of the development of experimental atherosclerosis by calcium antagonists has been reported. 8 -10 The Ca + + channel blockers, nifedipine 11 and verapamil, 12 have been shown to suppress atherogenesis in cholesterol-fed rabbits, while aortic, but not intramural, coronary atherosclerosis was affected by diltiazem and flunarizine. 13 In all of these studies, the degree of atherosclerosis was determined morphologically by staining the total aortic intima for lipid with Sudan IV. However, a more recent study 14 failed to demonstrate a protective effect of nifedipine on the accumulation of cholesterol in the different layers of the aorta in cholesterol-fed rabbits, as measured chemically and with radioactive tracers. Since verapamil is less labile than nifedipine and is widely used in cardiology, it was of interest to determine whether it affects LDL metabolism. In the present study, we examined the effect of verapamil on the interaction between the cellular constituents of the aortic wall and LDL using cells in culture. The results obtained indicate that verapamil in the micromolar range does influence receptor-mediated endocytosis of LDL.
Methods

Cell Cultures
Human skin fibroblasts (HSF), bovine aortic smooth muscle cells (SMC), and bovine aortic endothelial cells were obtained as described before. 1516 The HSF from a patient with homozygous familial hypercholesterolemia were purchased from the Human Genetic Mutant Cell Repository; these fibroblasts were designated as cell line GM-0701. The HSF, bovine aortic SMC (4 x 10 4 cells), and endothelial cells (7 x 10 4 cells) were plated in 35 mm petri dishes. The HSF were grown for 7 days with modified Eagle medium (MEM) containing 10% fetal bovine serum. The SMC were grown for 4 to 5 days with Dulbecco-Vogt MEM containing 5% fetal bovine serum and 5% newborn calf serum. Endothelial cells were grown for 10 days in Dulbecco-Vogt MEM containing 10% newborn calf serum, and were supplemented with fibroblast growth factor (FGF) for the first 6 to 8 days. Primary cultures of rat hepatocytes were prepared as described earlier; 17 these were used 24 hours after isolation.
Llpoproteins and Llposomes
Human LDL was isolated by ultracentrifugation according to Havel et al. 18 at d = 1.019 to 1.063 g/ml and was iodinated with 125 I as described before. 19 Labeling of LDL with 3 H cholesteryl linoleate (CL) was carried out by an adaptation of the method described for high density lipoprotein (HDL). 20 Intralipid, 125 fig triacylglycerol in 2 ml 0.9% NaCI, was sonicated twice for 30 seconds with 5 /iC\ of 3 H-CL (S.A. 9.5 Ci/mmol). LDL protein (5 mg) was incubated with the labeled Intralipid and the d > 1.25 g/ml fraction of human serum containing the cholesteryl ester transfer protein (30 mg protein/ml) for 18 hours at 37° C. Thereafter, the incubation mixture was brought to d = 1.019 g/ml with NaCI, and centrifuged for 24 hours in a SW41 rotor at 150,000 g. The top 1 ml was cut with the help of a tube slicer, and the clear subnatant was sterile-filtered through a 0.45 (i Millipore filter.
Unilamellar liposomes were prepared from rat liver, phosphatidyl choline, 3 H cholesteryl linoleyl ether, and 14 C-CL. 21 The lipids were subjected to ultrasonic irradiation with a Braun-Sonic 3000 instrument (Melsungen, West Germany) at 100 W output and a 9 mm probe. The sonicate was diluted with MEM medium containing 4% albumin (fatty acid-poor) and centrifuged for 3 hours in a SW41 rotor at 190,000 g. The tubes were sliced 1.5 ml from the top, and the clear infranatant was sterile-filtered. Human lipoprotein-deficient serum (LPDS) was obtained by removing lipoproteins by ultracentrifugation at d = 1.25 g/ml for 48 hours. 15 Synthesis of cholesteryl linoleyl ether (CLE) was carried out according to Halperin and Gatt, 22 and CL synthesis was done according to Goodman. 23 
Experimental Procedures
On the day of the experiment, the medium was removed, the cell layers were washed twice with phosphate-buffered saline (PBS), and then MEM containing LPDS (5 mg protein/ml) was added. Incubations were carried out at 37° C in a CO 2 air incubator. Upregulation of the LDL receptor 24 (when indicated) was carried out by exposure of the cells to medium containing LPDS (5 mg protein/ml), for 48 hours. At the end of the experiment, the medium was collected, the cell layer was washed thrice with PBS containing 0.2% bovine serum albumin (BSA) and thrice with PBS. The cells were released from the dish by exposure to 0.05% trypsin; 25 following inactivation of the trypsin by serum-containing medium, the cells were separated and washed by repeated centrifugation. The cellular uptake equaled the cellassociated label after trypsinization. The degradation equaled the 12s l-degradation products determined in the culture medium as previously described. 25 The total amount of LDL endocytosed equaled the sum of degradation and uptake. Cells incubated with 3 H-CL LDL or with labeled liposomes were extracted with chloroform/methanol (2:1), and lipids were separated according to Folch et al. 26 For separation of labeled free cholesterol (FC) and esterified cholesterol (EC) by thin layer chromatography (TLC), a solvent system of 5% ethyl acetate in hexane was used. Incubation of cells with liposomes was carried out in the presence of lipoprotein lipase (LPL) 5 fig protein/ml). 21 Radioactivity was determined with a beta scintillation spectrometer (Tri-Carb 2660, Packard, La Grange, Illinois). The scintillation fluid was 20% Triton X-100, 0.005% 1,4-bis(2-5-phenyloxazolyl)benzene (POPOP), and 0.4% 2,5diphenyloxazole (PPO) in toluene. 125 Endotheiiai cells (EC) were cultured for 10 days; smooth muscle cells (SMC) for 5 days in 35 mm petri dishes. On the day of the experiment, the serum containing culture medium was replaced by 1 ml of MEM containing lipoprotein-deficient serum (LPDS) (5 mg protein/ml) and 125 I-LDL (20 ug protein/ml) and verapamil where indicated. Cells were incubated for 24 hours. The medium was collected and used for determination of 125 I-LDL degradation products. The cells were washed thrice with 0.2% albumin in phosphate-buffered saline (PBS), thrice with PBS and released with trypsin. After the addition of serum containing medium to inactivate the trypsin, the cells were pelleted and washed by repeated centrifugation. Uptake designates cell associated radioactivity after trypsinization. Values are means ± SE of triplicate dishes.
Results
Bovine aortic endotheiiai cells and SMC were shown to interact with human LDL,' 5 and therefore the human lipoprotein was used in the present experiments. Confluent endotheiiai and SMC were exposed to LDL for 24 hours, and after this time interval, the amount of LDL degraded in the control 1^000 dishes was 2.5 to 6 times that retained in the cells after trypsinization ( Table 1 ). The addition of verapamil at 50 or 100 pM concentrations to both cell cultures resulted in a significant increase in LDL uptake and degradation. These experiments were then repeated with use of a homologous system, namely, human LDL and HSF. As seen in Figure 1 between 50 and 100 fxM, and in HSF a 70% increase in the cellular content of LDL was seen at 10 /J.M concentration (p < 0.02). In HSF the total amount of LDL endocytosed (sum of degradation and uptake) increased two-fold at both 50 and 100 /AM verapamil, but at 100 (iM, more LDL was retained in the cell, while at 50 /xM more had been degraded.
Table 2. Time Course of Verapamll Action on Uptake and Degradation of 125 I-LDL in Bovine Aortic Endothelial Cells and Human Skin Flbroblasts
In the next experiments, exposure to verapamil was prolonged to 48 hours. After this time, there was a doubling of cellular 125 I-LDL at 10 ^iM verapamil and it was sixfold at 50 /xM, as compared to controls. 125|-LDL degradation increased by 40% at 10 /xM and 2.6-fold at 50 /AM verapamil, as compared to controls. The time course of the verapamil effect was studied in HSF and endothelial cells. After 3 hours of incubation at 50 /u.M verapamil, the total amount of LDL endocytosed was not significantly different from control, but the amount degraded, especially in the HSF, was lower ( Table 2) . Similar results were obtained with SMC (data not shown). After 6 hours the amount of LDL degradation in both control and verapamil-treated endothelial cultures was similar, while the amount of cellular 12S I-LDL increased about 2.7-fold in endothelial cells and by 75% in HSF. At 24 hours, uptake and degradation were increased 130% to 150% in both cell types.
To compare the effect of verapamil on both components of the LDL particle (protein and cholesteryl ester), parallel dishes were incubated with 12S I-LDL or 3 H-CL-LDL and 50 /xM verapamil. Good agreement in the sum of uptake and degradation of 1 2 S I-LDL and the total cellular 3 H was seen in all experiments (Table 3) . Treatment with verapamil resulted in a 2-to 2.5-fold increase in 3 H-CL-LDL, which had been taken up by the cells after 18 to 24 hours. In control HSF and endothelial cells, 90% of the radioactivity recovered was in FC, and incubation with verapamil resulted in an increase in cellular 3 H-CL in both cell types (Table 3 ). Since verapamil affected the uptake and metabolism of the protein and cholesteryl ester moiety of LDL to a similar extent, the question arose as to whether this compound influenced surface binding as well.
The surface binding was determined by two methods: 1) the measurement of trypsin-releasable label after incubation of the cells with 125 I-LDL at 37° C for 6 or 24 hours; and 2) the measurement of heparinreleasable label in cells pretreated with verapamil for 24 hours and incubated with 125 I-LDL for 1 hour.
In the experiment with endothelial cells incubated with verapamil for 6 hours, trypsin-releasable label was increased signifiantly (p < 0.001), and it was doubled in all three cell lines after 24 hours of incubation (Table 4 ). Therefore, HSF were preincubated with verapamil for 24 hours and then incubated with I2S|.|_OL for 1 hour at 37° C. Specific binding was determined as heparin-releasable radioactivity corrected for nonspecific binding in the presence of 500 ng LDL protein/ml. The effect of verapamil pretreatment on the kinetics of LDL binding and uptake is shown in Figure 2 . A very significant increase in surface binding and in cellular content was seen at all concentrations of LDL used. The data in Figure 2 were linearized, and the calculated, apparent V ,( the maximal high affinity binding of 125 I-LDL; Figure  2 A) was 135 ng/mg cell protein in controls and 566 ng/mg cell protein in verapamil-treated cells. For cellular uptake, these values were 510 and 2141 ng/mg Human skin fibroblasts (HSF) were cultured for 7 days, and endothelial cells (EC) for 10 days. Incubation was carried out in modified Eagle medium containing lipoprotein-deficient serum (5 mg protein/ml) and 1 cell protein in the controls and verapamil-treated cells, respectively. In both instances, the differences between the control and experimental groups were statistically significant (p < 0.02). The apparent «", in the verapamil-treated cells was higher than in controls, but the difference was not statistically significant. Thus, verapamil appeared to act by increasing the number of LDL receptors rather than their affinity.
Additional evidence for the effect of verapamil on LDL metabolism was obtained in the experiments in which bovine aortic endothelial cells were pretreated with the drug for 24 hours and incubated with 1 2 5 I-LDL at 37° C for 3 and 7 hours ( Table 5 ). In contradistinction to the results presented in Table 2 , the increase in uptake and degradation in cells treated with verapamil was already evident after 3 hours of incubation with 12S I-LDL, so that the total amount of 125 I-LDL metabolized was doubled; this was true also for the 7-hour interval ( Table 5) .
To determine whether verapamil has to be present during incubation of the cells with LDL, and whether it might affect the LDL particle directly, we performed the following experiment. We incubated HSF in MEM-LPDS with or without verapamil for 24 hours. The medium was removed, the cells were washed with PBS and incubated for 3 hours or 24 hours with 125 I-LDL; no verapamil was added during incubation with 125 I-LDL. As seen in Table 6 , the total amount of LDL endocytosed (U + D) was increased at both time intervals. The lag in LDL degradation was apparent at the 3-hour interval, but not after 24 hours.
In the next experiments, we compared the uptake of LDL in receptor-upregulated and non-upregulated cells in the presence of 50 and 100 /xM verapamil. As The cells were chilled, washed as indicated in Methods, and incubated in Hepes-buffered NaCI with heparin (10 mg/ml). 6 Values are means of duplicates after subtracting the heparinreleasable or cellular label in the presence of carrier LDL from that in the absence of carrier. Cells were cultured for 10 days and then incubated for 24 hours in modified Eagle medium containing lipoprotein-deficient serum (5 mg protein/ml) and verapamil (50 /J,M) where appropriate. After 24 hours, ii5 l-LDL (20 ^g protein/ml) was added. Values are means ± SE of triplicate dishes. The human skin fibroblasts (HSF) were cultured for 6 days. On Day 1, the medium was replaced by 1 ml of modified Eagle medium (MEM) containing lipoprotein-deficient serum (LPDS) (5 mg protein/ml) and verapamil where indicated (50 /xM). After 24 hours of preincubation, the medium was removed, the cell layer washed twice with 2 ml phosphate buffered saline, and fresh MEM-LPDS containing 125 I-LDL (20 fjug protein/ml) was added. Verapamil was not present during incubation with 125 I-LDL. Other conditions are as in Table 1 . Values are means ± SE of triplicate dishes. Non-upregulated cells were cultured for 7 days; upregulated cells were cultured for 5 days and incubated in modified Eagle medium containing lipoprotein-deficient serum (MEM-LPDS) for 48 hours. All cells were then incubated for 24 hours in MEM-LPDS containing 125 I-LDL (20 /xg protein/ml) and where indicated, with verapamil. Values are means ± SE of triplicate dishes. seen in Table 7 , the addition of 50 /xM verapamil to non-upregulated cells resulted in a threefold increase in LDL endocytosis, as determined by the sum of uptake and degradation. In control upregulated cells, LDL degradation was threefold that seen in non-upregulated controls. The addition of 50 ^M verapamil to these cells increased cell-associated 125 I label, but the increase of LDL degradation was not commensurate with the increase in uptake. It is evident ( Table 7 ) that in both non-upregulated and upregulated cells, verapamil caused a similar increment in the amount of LDL endocytosed when compared to the respective controls. In the same experiment, we also used cells from an apo B receptor-negative donor and saw no increase of uptake or degradation of LDL in the verapamil-treated cells. Verapamil (100 /AM) was used in the second experiment shown in Table 7 to determine whether it might affect the apo B receptor-negative cells. Although at this concentration of verapamil the total amount of LDL endocytosed in non-upregulated and upregulated normal cells was increased, the degradation of LDL relative to the total endocytosed was reduced. However, no effect of verapamil was seen on the receptor-negative cells.
Table 5. Uptake and Degradation of 125 I-LOW Density Lipoproteln by Bovine Aortic Endothellal Cells Pretreated with Verapamil for 24 Hours
To determine whether verapamil stimulates the total amount of LDL endocytosed by affecting the cell cycle, we measured the incorporation of 3 H-thymidine in control and verapamil-treated cells in the presence of 20 ^g LDL protein/ml. After 5 hours and 24 hours of pretreatment with 50 fxM verapamil, an 80% reduction in 3 H-thymidine uptake and incorporation into DNA was seen. Thus, it appears that the verapamil effect on LDL cannot be attributed to a stimulation of the cell cycle. To ascertain whether the effect of verapamil was due to new receptor synthe-sis, we exposed SMC to verapamil in the presence and absence of cycloheximide. As seen in Table 8 , cotreatment with cycloheximide abolished the increase in the total amount of LDL endocytosed, but not the delay in the transfer of the ligand to the catabolic compartment.
The effect of verapamil on endocytosis not mediated by apo B receptor was investigated 21 with the use of milk LPL and liposomes labeled with 14 C-CL and 3 H-CLE. 21 Milk LPL was shown to promote uptake of liposomal CL and CLE into a trypsin-resistant cellular compartment from where the compounds were transferred to an intracellular metabolizing compartment. 28 The data in Table 9 are from experiments with four different types of cultured cells. It is evident See Table 1 for explanation of experiment. The concentration of verapamil was 50 ^M and of cycloheximide, 3.5 x 10~4M. Incubation was carried out for 24 hours. Values are means ± SE of triplicate dishes. a vs b, p < 0.01. 
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Cells were cultured in their respective culture media, as described in Methods. Incubation was carried out for 24 hours in MEM-LPDS containing the labeled liposomes, and verapamil where indicated. The percentage of free 14 that verapamil did not affect the transfer of 3 H-CLE or 1 *C-CL to the trypsin-resistant cellular compartment. However, when the percentage of 14 C-cholesterol formed was determined, it appeared that less hydrolysis of 14 C-CL occurred in the verapamil-treated cells ( Table 9 ). Although the mechanism of action of verapamil is considered to be mainly on the Ca++ channel, its methoxy derivative, D600, was shown to also inhibit Na uptake at /AM concentrations. 29 Therefore, in the next experiments, we studied the effect of sodium channel blockers, such as amiloride and tetrodotoxin (TTX) on 125 I-LDL uptake. The data in Table 10 show that after 6 and 24 hours of incubation with 1 piM of TTX, there was a modest increase in the amount of 
Discussion
In the present study, we investigated the effect of verapamil on the interaction between LDL and cellular constituents of the aorta in culture. The effect of verapamil on the total amount of LDL endocytosed was both time-and concentration-dependent. The increase in 126 I-LDL uptake occurred between 3 and 6 hours after exposure to verapamil; when the incubation was extended to 48 hours, the effect was markedly enhanced also at lower concentrations of verapamil (10 /xM). This increase in sensitivity with time could be due to the fact that verapamil may reach concentrations in membranes that are 10 to 20 times higher than their extracellular levels. 30 The results obtained with LDL labeled with 3 H-cholesteryl ester provided corroborative evidence that verapamil affected the uptake of the entire lipoprotein particle. The increase in the total amount of LDL endocytosed was also accompanied by an increase in the surface-bound lipoprotein that could be released by trypsin or heparin. The lack of effect on LDL uptake by apo B receptor-negative cells indicated that the drug affected primarily receptor-mediated endocyto- See Table 1 for explanation of experiment. The concentration of verapamil was 50 ^,M, of tetrodotoxin (TTX) 1 /xM, of amiloride 100 ^iM in 6 hours and 2 mM in the 24-hour experiment; tetraethylammonium chloride (TEA) was 20 mM. In each experiment, triplicate dishes were used for each data point; the SE of triplicates ranged between 5% and 10% of the mean. sis. This thesis was further supported in the experiments in which endocytosis of 3 H-CLE was mediated by LPL, an apo B receptor-independent process. 21 
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The role of ions in receptor-mediated endocytosis was studied with several ligands such as LDL, 6 a 2macrogobulin, 31 ' 32 and epidermal growth factor (EGF). 31 Depletion of intracellular potassium was shown to arrest coated-pit formation and receptormediated endocytosis of LDL. 6 Monovalent ionophores, such as monensin, inhibited receptor-mediated endocytosis of LDL 5 and aj-macroglobulin, 33 but to a lesser extent than that of EGF. Maximal receptor-mediated endocytosis also required the presence of Na + and HCO 3 , 31 ' M while the absence of Na + did not reduce the cellular uptake of horseradish peroxidase by fluid phase endocytosis. 31 In another system, calcium ionophore A 23187 reduced the uptake of albumin by endothelial cells. 34 It is relevant to point out that the effects of ions cited above were studied during relatively short time intervals, while in the present study the experiments were extended up to 48 hours.
The mechanism of action of verapamil is attributed to an inhibition of the influx of Ca+ + through the slow Ca + + channels situated in the plasma membrane of excitable cells, 35 but intracellular sites have also been proposed for some Ca + + channel inhibitors. 30 At higher concentrations, verapamil has a more complex action than a simple blockade of Ca + + channels. 36 At 30 to 200 fiM, verapamil was shown to also block active Na+ channels in synaptosomes. 36 Verapamil and its Na metoxy-derivative, D600, were shown to inhibit Na+ channels in embryonic heart, 37 cultured heart, and neuroblastoma cells. 29 The two compounds known to selectively inhibit voltage-sensitive Na + channels in smooth muscles were TTX 38 and amiloride. 3839 In our experiments, concentrations of amiloride 0.1-2 mM did not affect the uptake of LDL. On the other hand, 1 fiM TTX did increase the total amount of LDL endocytosed, but did not impede LDL degradation. A more selective calciumchannel blocker, nifedipine, 40 was not used in the present study because it is rapidly inactivated by light and poorly soluble in culture media.
The time sequence of the presently described verapamil effect suggested a biphasic process. At the earliest time interval studied (3 hours), the amount of LDL endocytosed was not increased, but there was a decrease in the fraction of the LDL protein that had undergone hydrolysis. This finding could have been due to a delay in the delivery of the ligand to the lysosome or to an inhibition of lysosomal degradation. 41 This delay in protein degradation was also apparent at later time intervals ;vhen an increase in the total amount of endocytosed LDL had occurred. Moreover, hydrolysis of LDL cholesteryl ester was also affected, so that even though equal amounts of 3 H-FC were formed in control and verapamil-treated cells, an accumulation of 3 H-cholesteryl ester had occurred. In addition, cholesteryl ester that had been endocytosed with the help of LPL (not via the LDL receptor), was also hydrolyzed less extensively than in control cells. Delay in chylomicron remnant protein 42 and cholesteryl ester 43 degradation was previously observed in experiments with colchicine and rat liver cells and was attributed to an interference in fusion between the endocytic vesicle and lysosomes. One could envisage the possibility that verapamil might change the distribution of intracellular Ca+ + and thus affect the fusion between endosomes and lysosomes. 44 It cannot be stated yet which of the possible actions of verapamil on ion flux was responsible for the increase in LDL endocytosis. The possibility considered was that verapamil, via its action on Na+ flux, could act in a manner opposite to the Na ionophore monensin, 5 namely, by enhancing receptor recycling. However, the dependence of the verapamil effect on protein synthesis suggests that increased receptor recyling may not provide the whole explanation.
Even though the doses of verapamil effective in the present experiments were higher than those used in vivo, our results might have relevance to in vivo conditions, because verapamil in the myocardium can reach concentrations up to nine times higher than in plasma. 45 We do not know whether one may extrapolate from the present findings in culture to the in vivo findings of other investigators. One could envisage a possibility that in the highly hypercholesterolemic rabbit, the LDL receptors are maximally down-regulated. Verapamil-induced stimulation of receptors in the cellular constituents of the aorta could aid in the removal of LDL cholesteryl ester from the aortic interstitium, without affecting plasma cholesterol levels. 11 -13 
